Key points are not available for this paper at this time.
Three pyrazolone-based ligands, namely 1-phenyl-3-methyl-4-(1-naphthoyl)-5-pyrazolone (HL1), 1-phenyl-3-methyl-4-(4-dimethylaminobenzoyl)-5-pyrazolone (HL2), and 1-phenyl-3-methyl-4-(4-cyanobenzoyl)-5-pyrazolone (HL3), were synthesized by introducing electron-poor or electron-rich aryl substituents at the 4-position of the pyrazolone ring. Their corresponding europium complexes Eu(LX)3(H2O)2 and Eu(LX)3(TPPO)(H2O) (X = 1-3) were characterized by photophysical studies. The characteristic Eu(III) emission of these complexes with at most 9.2 x 10(-3) of fluorescent quantum yield was observed at room temperature. The results show that the modification of ligands tunes the triplet energy levels of three pyrazolone-based ligands to match the 5D0 energy level of Eu3+ properly and improves the energy transfer efficiency from antenna to Eu3+, therefore enhancing the Eu(III) emission intensity. The highest energy transfer efficiency and probability of lanthanide emission of Eu(L1)3(H2O)2 are 35.1% and 2.6%, respectively, which opens up broad prospects for improving luminescent properties of Eu(III) complexes by the modification of ligands. Furthermore, the electroluminescent properties of Eu(L1)3(TPPO)(H2O) were also investigated.
Shi et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: